(Q41844925)

13 October 2017

Pneumococcal conjugate vaccine for adults: a new paradigm (English)

1 reference

pneumococcal conjugate vaccine

13 October 2017

0 references

author name string

Peter R Paradiso

series ordinal

1

1 reference

PMC publication ID

3381637

13 October 2017

language of work or name

English

0 references

publication date

11 April 2012

1 reference

Clinical Infectious Diseases

13 October 2017

1 reference

13 October 2017

55

1 reference

13 October 2017

2

1 reference

13 October 2017

259-264

1 reference

Advances in pneumococcal disease prevention: 13-valent pneumococcal conjugate vaccine for infants and children

13 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3381637

A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3381637

Vaccines for preventing pneumococcal infection in adults

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3381637

Combined schedules of pneumococcal conjugate and polysaccharide vaccines: is hyporesponsiveness an issue?

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3381637

23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3381637

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3381637

Hyporesponsiveness following booster immunization with bacterial polysaccharides is caused by apoptosis of memory B cells.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3381637

Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3381637

Determining the optimal pneumococcal vaccination strategy for adults: is there a role for the pneumococcal conjugate vaccine?

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3381637

Clinical and economic burden of pneumococcal disease in older US adults.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3381637

Surveillance of certain health behaviors and conditions among states and selected local areas - Behavioral Risk Factor Surveillance System, United States, 2007.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3381637

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3381637

Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3381637

Revaccination with the 23-valent pneumococcal polysaccharide vaccine in middle-aged and elderly persons previously treated for pneumonia

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3381637

Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP)

18 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22495545

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22495545

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Advances in pneumococcal vaccines: the 13-valent pneumococcal conjugate vaccine received market authorization in Europe

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22495545

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/CID/CIS359

1 reference

13 October 2017

1 reference

PMC publication ID

3381637

13 October 2017

PubMed publication ID

22495545

1 reference

PMC publication ID

3381637